Skip to content
Research use onlyComplimentary shipping on orders over $200 U.S. fulfillment
Musculoskeletal & Growth

Sermorelin

$75Per vial

A 29-amino-acid GHRH analogue studied in growth hormone-releasing research, commonly used to examine somatotropic axis activity in laboratory models. As the shortest fully functional GHRH fragment, it serves as a foundational tool in GH secretion and pituitary signaling studies.

Vial size1 option

Backordered · Ships as soon as restocked

1
Complimentary shipping over $200 U.S.-based fulfillment
Ships as soon as this size is restocked
Record pending for this size

A certificate for this size has not been published yet. Documentation is added as it is received.

For laboratory research only. Not for human or veterinary use.

About Sermorelin

Sermorelin Overview

Sermorelin is a 29-amino-acid analogue of growth hormone-releasing hormone and is widely described as the shortest synthetic fragment that retains the full biologic activity of native GHRH. In research settings, it is used to examine GHRH receptor signaling and how upstream hypothalamic peptide activity influences downstream growth hormone pathway function.

Mechanism of Action & Applications

Sermorelin is studied for agonist activity at the growth hormone-releasing hormone receptor. In laboratory research, this makes it useful for examining pituitary signaling, pulsatile growth hormone release dynamics, receptor activation patterns, and broader endocrine pathway regulation linked to the hypothalamic-pituitary-somatotropic axis.

Research History

Research on sermorelin developed from earlier work on GHRH analogues designed to preserve biologic activity while using a shorter, more defined peptide fragment. Published reviews and earlier comparative studies describe sermorelin as a well-established GHRH analogue used in both endocrine and receptor-signaling research.

Chemical Information

CAS Number
86168-78-7
Molecular Formula
C149H246N44O42S
Molecular Weight
3,357.9 g/mol
PubChem ID
16132413

Researcher Reviews